Rosuvastatin Completed Phase 1 Trials for Metabolic Diseases Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT03395470Safety, Tolerability and PK of PXL770 in Healthy Male Subjects